Introduction
Folates play signiˆcant roles in the synthesis of nucleotides and the metabolism of amino acids, and are essential nutrients for cell growth. Reduced folate carrier (RFC1, SLC19A1) is responsible for the transport of folates and their analogs across biological membranes in mammalian cells. 1) RFC1 cDNAs of mouse, hamster and human have been cloned. [2] [3] [4] [5] [6] [7] [8] In humans, RFC1 is expressed in various tissues, including the small intestine, placenta, brain, liver and kidney. 2, [9] [10] [11] In the small intestine, the carrier exists at not only the brush border membrane but also at the basolatelal membrane of the intestinal epithelial cells. [12] [13] [14] [15] RFC1 located at the brush border membrane is reported to transport folates using a H ＋ gradient as a driving force. 13, 14, 16) Methotrexate (L-amethopterin, L-MTX) is used clinically as an antineoplastic and antirheumatic drug. Because of the similarity in molecular structure to folic acid, orally administered L-MTX is absorbed by RFC1 in the small intestine. Indeed, human RFC1 from the small intestine has been cloned and shown to transport L-MTX using a H ＋ gradient as a driving force. 2, 17) D-Amethopterin (D-MTX) is the optical isomer of L-MTX, and the absorption of D-MTX from the human small intestine is signiˆcantly lower than that of L-MTX. It is reported that the area under the plasma concentration-time curve (AUC) following oral administration of L-MTX is approximately 40-fold greater than that following D-MTX administration. 18) In our previous study using brush border membrane vesicles (BBMV) prepared from the small intestines of rabbits, the a‹nity of L-MTX to rabbit RFC1 was approximately 60-fold greater than that of D-MTX. 19) The present study was conducted to examine the stereoselectivity of human RFC1 using Caco-2 cells. Since RFC1 is expressed in Caco-2 cells, this cell line is suitable for studying the stereoselectivity of human RFC1. 20) In our previous report, the stereoselectivity of RFC1 in Caco-2 cells was studied using folic acid (FA) as a model substrate. 21) It is also reported by other groups that FA is transported by RFC1 with a Km value being similar to that of L-MTX. 2, 14, 22, 23) However, there are reports which show that the a‹nity of FA is much smaller than that of reduced folates and that the transport rate of FA is much smaller than that of L-MTX.
In the present study, the stereoselectivity of RFC1 was examined using L-MTX, one of the reduced folates. Moreover, the diŠerences between MTX enantiomers were investigated not only for the a‹nity to but also for the transport by RFC1 with the use of LC-MS W MS analysis. 21 and 28 days before being used in the uptake studies. Culture conditions were the same as those reported previously. 26) Cells between the 30th and 40th passages were used in the present study.
Materials and Methods

Materials
Uptake study: Hank's balanced salt solution (HBSS: 145 mM NaCl, 3 mM KCl, 1 mM CaCl2, 0.5 mM MgCl2) containing 5 mM D-glucose and 5 mM MES (for pH 6.0) was used as the uptake medium. HBSS containing 5 mM D-glucose and 5 mM HEPES (for pH 7.4) was used as the rinse medium.
For the uptake study, Caco-2 cells in six-well plates were rinsed twice and pre-incubated with the rinse medium (pH 7.4) for 10 min at 379 C. Uptake was initiated by adding 1 mL of the pre-incubated drug solution. The drug solution was the uptake medium (pH 6.0) containing 3 H-L-MTX, unlabeled L-MTX, or D-MTX. The drug solution was aspirated at the appropriate time in order to terminate the uptake. The cells were rinsed twice with ice-cold rinse medium (pH 7.4), then lysed with 1 mL of 0.1z Triton } X-100. To determine the uptake amount of 3 H-L-MTX, a 0.8 mL aliquot of the cell lysate was transferred to a scintillation vial, then 10 mL of Aquasol-2 TM (Packard Instrument Co., Meriden, CT, U.S.A.) was added, and the radioactivity was measured by liquid scintillation counting. To determine the uptake amount of unlabeled L-MTX and D-MTX, a 1 mL aliquot of the cell lysate was mixed with 1 mL of acetonitrile and then vortexed.
The mixture was then centrifuged at 825 g for 15 min and the supernatantˆltered with a Millex } -HVˆlter (0.45 mm; Millipore, Bedford, MA, U.S.A.). Thê ltrate was dried under a gentle stream of nitrogen gas at 809 C 27) and the residue dissolved in 100 mL of the mobile phase (see below). A 20 mL aliquot was injected into an LC-MS W MS.
Adsorption of the drug to the cells was measured in the manner described above, but the drug solution was removed immediately after being added to the plate. The adsorbed amount was subtracted to obtain the net uptake. In the inhibition study, each inhibitor was added to the drug solution at an appropriate concentration, and uptake of the drug was measured in the manner described above. Drugs and inhibitors were dissolved in dimethylsulfoxide (DMSO) and theˆnal concentration of DMSO in the drug solution was 5z or less.
LC-MS W MS conditions: A Waters Micromass tandem quadrupole Quatro micro mass spectrometer (Waters, Milford, MA, U.S.A.) was interfaced with the HPLC system via an electrospray ionization probe in the negative ion mode. The analytical column of HPLC was Inertsil } ODS-3 (5 mm in particle size, 2.1×150 mm; GL Sciences Inc., Tokyo, Japan). The mobile phase was solvent A (10 mM ammonium acetate, 0.05z formic acid and 1z isopropyl alcohol in water): solvent B (0.05z formic acid and 1z isopropyl alcohol in acetonitrile)＝9:1 (v W v). The ‰ow rate was 0.2 mL W min, and an eluent between 6 and 8 min was introduced into the mass spectrometer. The ionization conditions were as follows: capillary voltage: 2.9 kV; cone voltage: 48 V; collision energy: 22 eV; source temperature: 1509 C; desolvation temperature: 2209 C; collision gas: argon. The sample was analyzed during the multiple reaction monitoring (MRM) mode of the mass spectrometer at a dwell time of 2 s per channel using m W z 453.08À324.08 as the transition.
Protein assay: For protein determination, Caco-2 cells were dissolved in 1 mL of 0.1z Triton } X-100 and the protein concentration was determined with a Bio-Rad protein assay kit (Bio-Rad Laboratories, Richmond, CA, U.S.A.) using bovine serum albumin as a standard.
Data analysis: To calculate kinetic parameters for L-MTX uptake, the data wereˆt to the following equation (Eq.1) by a non-linear least-squares method. 28) v＝
where v is the initial uptake rate, V max is the maximum uptake rate, Km is the Michaelis constant, kd is the uptake clearance by passive diŠusion, and [S] is the initial concentration of the drug. Statistical analysis: Statistical analysis was conduct- ed using Student's t-test.
Results
Time course of L-MTX uptake: The time course of 0.02 mM 3 H-L-MTX uptake in the presence of a H ＋ gradient (pH 6.0) is shown in Fig. 1 . Since the amount taken up in the cells increased linearly for up to 15 min, the initial uptake rate was calculated from the uptake amount at 5 min in the following studies. Concentration dependence of L-MTX uptake: The initial uptake of 3 H-L-MTX at various concentrations (0.02-20 mM) were measured in the presence of a H ＋ gradient (pH 6.0). The results are shown in Fig. 2 H-L-MTX was measured at concentrations ranging from 0.5 to 200 mM in the presence of a H ＋ gradient. The uptake by passive diŠusion was calculated by multiplying the above kd value (0.270 mL W min W mg protein) by the L-MTX concentration, and the RFC1-mediated uptake was calculated by subtracting the uptake from passive diŠusion from the total uptake. An Eadie-Hofstee plot of the RFC1-mediated uptake (Fig. 3) indicated that the saturable uptake of L-MTX into Caco-2 cells was mediated by a single transport system.
Inhibition studies: The inhibitory eŠects of 1 mM probenecid, 1 mM DIDS, 50 mM FCCP and 10 mM AMT on 0.02 mM 3 H-L-MTX uptake were studied. The results are summarized in Table 1 . L-MTX uptake was inhibited by probenecid and DIDS, which are inhibitors of organic anion transport systems such as OATs and OATPs, and AMT, which is a folate analog. FCCP, a protonophore, also inhibited L-MTX uptake, thus conˆrming that the proton gradient was the driving force for the uptake of L-MTX into Caco-2 cells.
The inhibitory eŠects of folic acid (FA), unlabeled L-MTX and D-MTX on 3 H-L-MTX uptake were also studied ( Table 1) . L-MTX uptake was signiˆcantly inhibited by 2 and 100 mM of FA. The uptake was also signiˆcantly inhibited by 2 and 100 mM of unlabeled L-MTX. In contrast, 2 mM of D-MTX did not aŠect L-MTX uptake, and the inhibitory eŠect was obvious when 100 mM or 1 mM of D-MTX was added.
The initial uptake rates of 0.1 and 2 mM of 3 H-L-MTX were measured in the presence of 0, 0.5, 1 and 2 mM of FA, and the data were analyzed using a Dixon plot (Fig. 4-A) . FA competitively inhibited L-MTX uptake with a Ki value of 0.80 mM. The initial uptake rates for 0.1 and 2 mM of 3 H-L-MTX were also measured in the presence of 0, 1, and 2 mM of unlabeled L-MTX. The Dixon plot showed that unlabeled L-MTX competitively inhibited 3 H-L-MTX uptake with a Ki value of 1.51 mM (Fig. 4-B) . Furthermore, the initial uptake rates for 0.5, 1, and 5 mM of L-MTX were measured in the presence of 0, 100, and 200 mM of D-MTX. According to the Dixon plot (Fig. 4-C) , D-MTX also inhibited L-MTX uptake competitively with a Ki value of 185 mM.
Uptake of L-and D-MTX: Uptake amounts of unlabeled L-and D-MTX at 0.5 mM into Caco-2 cells in the presence of a H ＋ gradient (pH 6.0) were measured using LC-MS W MS analysis. The results are shown in Fig. 5 . The uptake of L-MTX was signiˆcantly greater than that of D-MTX at all time points. The uptake rates were calculated from the slope, and divided by the initial concentration (0.5 mM) to obtain the uptake clearance. The obtained uptake clearance values were 0.903 and 0.130 mL W min W mg protein for L-and D-MTX, respectively, which revealed an approximately 7-fold diŠer-ence in uptake rate between the enantiomers.
Discussion
Caco-2 cells are used widely as an in vitro model to estimate intestinal absorption of drugs. Most transporters expressed in human enterocytes are expressed in Caco-2 cells, although the expression levels appear to diŠer from those in intestinal epithelial cells in vivo, depending on the transporter. Since RFC1 is expressed in Caco-2 cells, 20) this cell line was used in the present study to examine transport characteristics of human RFC1.
In the present study, we deˆned the carrier-mediated uptake of L-MTX into Caco-2 cells``the RFC1-mediated uptake'', which may be inappropriate because it is possible that the uptake is not mediated by RFC1. However, we believe the present uptake into Caco-2 cells is mediated by RFC1 for the following reasons. Firstly, there are numerous reports that L-MTX is a substrate of RFC1. Secondly, the carrier-mediated uptake of L-MTX into Caco-2 cells consisted of a single component (Fig. 3) with the Km value being very similar to the reported Km values to RFC1 (see below). Thirdly, L-MTX uptake into Caco-2 cells was correlated with RFC1 mRNA levels. In our preliminary study, L-MTX uptake and the RFC1 mRNA levels were measured using Caco-2 cells with various culture days. The results revealed a correlation between L-MTX uptake and RFC1 mRNA levels (data not shown). Based on these observations, the carrier-mediated uptake of L-MTX was deˆned``the RFC1-mediated uptake'' in the present study.
The initial uptake rate of L-MTX was concentration dependent with a Km value of 1.31 mM (Fig. 2) . This Km value is similar to those previously reported, which are 1.54 mM in rat intestinal BBMV, 12) 2.65 mM in mouse L1210 cells, 29) 1.65-3.15 mM in K562 cells transfected with human RFC1 cDNA. [30] [31] [32] Since the Eadie-Hofstee plot of the saturable uptake of L-MTX showed a straight line (Fig. 3) , L-MTX uptake into Caco-2 cells is apparently mediated by a single transport system, RFC1, in the concentration range used in this study.
In the inhibition studies, L-MTX uptake decreased to 36z and 21z of the control in the presence of 1 mM probenecid and DIDS, respectively ( Table 1) . These results agree with those of previous reports. RFC1-mediated transport decreased to 30z and 10z in the presence of 1 mM probenecid and DIDS, respectively, in murine L1210 leukemia and RFC1 expressed cells. 22, 33) Approximately 70z inhibition of L-MTX uptake by 10 mM AMT is also in agreement with the Ki value (5.4 mM) of AMT to RFC1. 34) Assuming competitive inhibition, 10 mM of AMT with a K i value of 5.4 mM should inhibit 65z of RFC1-mediated transport. Moreover, the inhibition by FCCP indicates that the driving force of L-MTX uptake is a H ＋ gradient. These results support the idea that L-MTX uptake into Caco-2 cells in the presence of a H ＋ gradient is mediated by RFC1.
FCCP works as a mitochondrial uncoupler 35, 36) as well as a protonophore. 37, 38) When FCCP is used as a mitochondrial uncoupler, the cells are usually incubated with FCCP for 45-90 min. In contrast, if FCCP is used as a protonophore, FCCP is added to the cells together with a substrate. Under the present experimental conditions, it is most likely that FCCP works as a protonophore, not as a mitochondrial uncoupler. In order to further conˆrm the H ＋ gradient as a driving force, membrane vesicles that are prepared from Caco-2 cells may have to be used.
It is known that L-MTX is a substrate of MRP2 and BCRP, and that these eOEux transporters are present in Caco-2 cells. Since probenecid is an inhibitor of both RFC1 and MRP2, probenecid may inhibit both the uptake by RFC1 and the eOEux by MRP2. When probenecid is used as an inhibitor of MRP, however, the cells are incubated with a MRP substrate and probenecid (an inhibitor) for 60-90 min, and then the accumulation of a substrate in the cells is measured. 39, 40) In the present inhibition study, L-MTX and probenecid were added to Caco-2 cells simultaneously, and the uptake of L-MTX in 5 min was measured. Therefore, it is unlikely that probenecid inhibited the eOEux of L-MTX under the present experimental conditions. L-MTX uptake decreased signiˆcantly in the presence of 2 and 100 mM of FA or unlabeled L-MTX. In contrast, L-MTX uptake was not in‰uenced by 2 mM of D-MTX, but decreased signiˆcantly in the presence of 100 mM and 1 mM of D-MTX ( Table 1 ). The results indicate that D-MTX is capable of binding to RFC1 with an a‹nity much lower than that of L-MTX.
The Dixon plot showed that L-MTX uptake was inhibited competitively by FA with a K i value of 0.80 mM (Fig. 4-A) . This Ki value is almost equal to the previously obtained Km value of FA in Caco-2 cells (Km＝0.57 mM). 21) These Km and Ki values of FA are similar to other reported values (Km＝0.9-1.4 mM and K i ＝0.5-2 mM). 2, 12, 13, 17, 22, 23, 41) Unlabeled L-MTX and D-MTX competitively inhibited the uptake of 3 H-labeled L-MTX with Ki values of 1.51 and 185 mM, respectively (Figs. 4-B and C) . The results clearly demonstrate that the a‹nity of L-MTX to RFC1 is comparable to that of FA, and that the a‹nity of D-MTX to RFC1 is approximately 120-fold smaller. These results are consistent with our previous observations using rabbit intestinal brush border membrane vesicles, which showed that the a‹nity of L-MTX to RFC1 was 60-fold greater than that of D-MTX. 19) The uptake clearance of each enantiomer was calculated from the slope of the uptake rate (Fig. 5) , which were 0.903 and 0.130 mL W min W mg protein for L-and D-MTX, respectively. On the other hand, the uptake clearance values by RFC1 and passive diŠusion at a concentration of 0.5 mM of L-MTX were calculated using the uptake parameters obtained in Fig. 2 , which were 0.686 and 0.217 mL W min W mg protein, respectively. The results indicate that 76z of the total uptake is carrier-mediated at a concentration of 0.5 mM of L-MTX. When these values are compared with the uptake clearance of D-MTX at the same concentration, the uptake clearance of D-MTX (0.130 mL W min W mg protein) is similar or slightly smaller than that of L-MTX by passive diŠusion (0.217 mL W min W mg protein). The results suggest that D-MTX is taken up mainly by passive diŠusion with very little or no contribution from RFC1. Although the total uptake clearance (RFC1 plus passive) of L-MTX is 7-fold greater than that of D-MTX (Fig. 5) , RFC1-mediated uptake of L-MTX is expected to be much greater than that of D-MTX. Studies are underway to obtain uptake parameters for L-and D-MTX in order to reveal the stetreoselectivity of RFC1 in more detail.
It may be due to the diŠerences in MRP2-mediated eOEux between L-and D-MTX that the uptake clearance of D-MTX (0.130 mL W min W mg protein) is smaller than that of L-MTX by passive diŠusion (0.217 mL W min W mg protein). It is reported that both L-and D-MTX are transported by rat mrp2 and that the a‹nity of D-MTX to rat mrp2 is 3.5-fold greater than that of L-MTX. 42) Since MRP2 is expressed in Caco-2 cells, it is possible that D-MTX is eOEuxed from the cells at a rate faster than that of L-MTX, which may result in a smaller uptake of D-MTX. The eŠect of MRP2 on the uptake of L-and D-MTX is not known, yet.
When an equal dose of each amethopterin enantiomer was orally administered to humans, L-MTX concentrations in plasma were markedly greater than those of D-MTX.
18) The area under the plasma concentrationtime curve (AUC) of L-MTX was approximately 40-fold greater than that of D-MTX. Since the elimination rate constant of D-MTX was only 1.7-fold greater than that of L-MTX following intravenous administration of each enantiomer, the marked diŠerence in AUC between the enantiomers following oral administration is probably due to the stereoselectivity in intestinal absorption. These results in humans are consistent with the marked stereoselectivity of RFC1 observed in the present study.
Assuming that a normal dose of L-MTX (10 mg) is orally administered with 200 mL of water and completely dissolved in the stomach, the estimated maximum concentration of L-MTX in the GI tract will be approximately 100 mM. This concentration is much greater than the K m value of L-MTX to RFC1 (1.31 mM), suggesting that RFC1-mediated transport is saturated and that passive diŠusion may predominate in the intestinal absorption. On the other hand, when the intestinal absorption of L-MTX is predicted based on the molecular polar surface area, L-MTX should be very poorly absorbed if it is absorbed only by passive diŠusion. [43] [44] [45] Moreover, it is reported that higher doses of L-MTX result in reduced absorption. 46) These observations support the idea that L-MTX is absorbed in the small intestine mainly by a carrier-mediated process, i.e., RFC1, and not by passive diŠusion.
The present study showed that the a‹nity of L-MTX to RFC1 is approximately 120-fold greater than that of D-MTX. It also showed that L-MTX is taken up into Caco-2 cells mainly by RFC1, whereas D-MTX uptake occurs mainly by passive diŠusion with very little or no contribution of RFC1. It is very likely that the signiˆcant diŠerences in the oral absorption of amethopterin enantiomers re‰ect the stereoselectivity of human RFC1.
